The first is misleading ads.
"He did so voluntarily," the agency said.
``Coming to that conclusion, it took our breath way,'' Neaton said.
``I was stunned,'' said Kim who had expected positive results.
By then, Kim said, he was leaning toward pulling the drug.
(On Friday, Pfizer Inc. issued a warning that its Cox-2 drug Bextra may increase cardiovascular risk for some patients.)
``I thought the risk was going to be larger than it was,'' he said.
``This morning Merck is announcing a voluntary worldwide withdrawal of Vioxx,'' Gilmartin began.
But taking the drug off the market, he said, was the right thing, too.
